NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Care Facilities · USD

Concord Medical Services Holdings Limited (CCM) Stock Analysis

Concord Medical Services Holdings Limited (CCM) is a Medical Care Facilities stock listed on NYSE and quoted in US Dollar.

CCM

$4.68

+$0.22 (+4.93%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CCM with… →

CCM Key Statistics

As of Sep 4, 2026
Trading
Open
$4.57
Previous Close
$4.46
Day's Range
4.40–4.68
52-Week Range
3.18–6.98
Volume
11.10K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
−0.94
Valuation
Market Cap
$20.32M
P/E Ratio
unprofitable
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.56
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.04
EPS (ttm)Profit attributable to each share over the last twelve months.
−3.17
Financials (FY)
Revenue (FY)
$460.51M+19.94%
Net Income (FY)
−$92.81M
Profit marginThe share of revenue left as profit after all costs and taxes.
−20.15%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
2.82M
1-Year Return
−10.69%
Dividend and dates
Avg Volume
73.05K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

CCM Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+21.24%
2025−28.25%
2024−51.09%
2023−32.93%
2022−18.00%
2021−27.01%
2020+2.62%
2019−25.00%
2018+6.91%
2017−27.61%
2016 (partial year)+6.48%

As of September 4, 2026.

CCM Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$460.51M−$92.81M−20.2%
2024$383.96M−$308.24M−80.3%
2023$537.40M−$297.66M−55.4%
2022$472.09M−$489.66M−103.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$460.51M$25.82M−$239.33M−$92.81M−20.2%
2024$383.96M−$79.16M−$532.16M−$308.24M−80.3%
2023$537.40M−$76.61M−$462.99M−$297.66M−55.4%
2022$472.09M−$152.41M−$525.05M−$489.66M−103.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

CCM Valuation vs Medical Care Facilities Median

Median of 57 stocks
MetricCCMMedical Care Facilities medianvs median
P/S ratio0.040.950.0x the median
Profit margin−20.15%3.06%23.2 pts below

Medians across 57 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

The market values Concord Medical Services Holdings Limited (CCM) at $20.32M. It is classified in the Medical Care Facilities industry, within the Healthcare sector. Headcount on file is 610.

The most recent close on file for CCM is $4.68, dated September 4, 2026. That is +$0.22 (+4.93%) against the previous close. Over the past 52 weeks the price has ranged from $3.18 to $6.98. The latest close sits 47.17% above that 52-week low.

Financial Health

In fiscal 2025, Concord Medical Services Holdings Limited reported revenue of $460.51M. That is +19.94% against the prior fiscal year, when revenue was $383.96M. The same year closed with a net loss of $92.81M. Profit margin runs at −20.15%. That is 23.2 percentage points below the Medical Care Facilities median of 3.06%. Earnings per share on a trailing basis come to −3.17.

Across the 4 fiscal years on file, revenue moves from $472.09M in 2022 to $460.51M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.56. The price-to-sales ratio is 0.04. On price-to-sales that is 0 times the Medical Care Facilities median of 0.95. The medians here are taken across 57 Medical Care Facilities companies that report the metric.

The reported beta is −0.94. Annualized volatility over the trailing 10 years is 124.02%. The trailing one-year price return is −10.69%. Across 10 years the annualized return works out at −19.78%.

Growth & Income

No dividend is on file for CCM.

The strongest complete calendar year on file is 2018 at +6.91%; the weakest is 2024 at −51.09%. Of the 9 complete calendar years on file, 2 finished higher. So far in 2026 the price is +21.24%.

Peer Comparison

Concord Medical Services Holdings Limited (CCM) operates in the Medical Care Facilities industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Concord Medical Services Holdings Limited CCM $20.32M —
HCA Healthcare, Inc. HCA $87.68B 13.6
Tenet Healthcare Corporation THC $21.34B 10.2
Fresenius Medical Care AG FMS $12.06B 11.7

The Medical Care Facilities industry average P/E ratio is 19.8x. Concord Medical Services Holdings Limited has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Care Facilities Stocks

HCA

HCA Healthcare, Inc.

$87.68B

 THC

Tenet Healthcare Corporation

$21.34B

 FMS

Fresenius Medical Care AG

$12.06B

 EHC

Encompass Health Corporation

$12.01B

 DVA

DaVita Inc.

$11.74B

 UHS

Universal Health Services, Inc.

$10.00B
View all Medical Care Facilities stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Concord Medical Services Holdings Limited

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, and helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.

Visit website →